StockData
Dyadic International Inc logo

Dyadic International Inc (DYAI) stock

DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.32+0.00 (+1.30%)

Close on Nov 18, 2026Market cap $11.66MP/E –Yield –

Dyadic International operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Dyadic International's operating income for the twelve months ending Sep 30, 2026 was -$7.31M. For fiscal 2025 it was -$7.19M. The highest annual figure on record is -$5.90M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.19M–
FY2024Dec 31, 2024-$5.90M–
FY2023Dec 31, 2023-$8.23M–
FY2022Dec 31, 2022-$10.17M–
FY2021Dec 31, 2021-$14.73M–
FY2020Dec 31, 2020-$10.03M–
FY2019Dec 31, 2019-$9.28M–
FY2018Dec 31, 2018-$7.59M–
FY2017Dec 31, 2017-$7.13M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$1.81M–
Q2 FY2026Jun 30, 2026-$2.05M–
Q1 FY2026Mar 31, 2026-$1.90M–
Q4 FY2025Dec 31, 2025-$1.54M–
Q3 FY2025Sep 30, 2025-$1.93M–
Q2 FY2025Jun 30, 2025-$1.73M–
Q1 FY2025Mar 31, 2025-$2.00M–
Q4 FY2024Dec 31, 2024-$1.53M–
Q3 FY2024Sep 30, 2024-$202.61K–
Q2 FY2024Jun 30, 2024-$2.04M–
Q1 FY2024Mar 31, 2024-$2.13M–
Q4 FY2023Dec 31, 2023-$2.17M–
Q3 FY2023Sep 30, 2023-$1.72M–
Q2 FY2023Jun 30, 2023-$2.29M–
Q1 FY2023Mar 31, 2023-$2.05M–
Q4 FY2022Dec 31, 2022-$2.24M–
Q3 FY2022Sep 30, 2022-$1.86M–
Q2 FY2022Jun 30, 2022-$3.32M–
Q1 FY2022Mar 31, 2022-$2.74M–
Q4 FY2021Dec 31, 2021-$4.22M–
Q3 FY2021Sep 30, 2021-$3.32M–
Q2 FY2021Jun 30, 2021-$3.87M–
Q1 FY2021Mar 31, 2021-$3.32B–
Q4 FY2020Dec 31, 2020-$2.27M–
Q3 FY2020Sep 30, 2020-$2.58M–
Q2 FY2020Jun 30, 2020-$2.80M–
Q1 FY2020Mar 31, 2020-$2.38M–
Q4 FY2019Dec 31, 2019-$1.94M–
Q3 FY2019Sep 30, 2019-$1.94M–
Q2 FY2019Jun 30, 2019-$2.96M–
Q1 FY2019Mar 31, 2019-$2.44M–
Q4 FY2018Dec 31, 2018-$1.77M–
Q3 FY2018Sep 30, 2018-$1.78M–
Q2 FY2018Jun 30, 2018-$1.82M–
Q1 FY2018Mar 31, 2018-$2.23M–

More Dyadic International figures

See a number that looks wrong?